DEHYDROEPIANDROSTERONE (DHEA) - ANVISA Registration 80048490099
Access comprehensive regulatory information for DEHYDROEPIANDROSTERONE (DHEA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80048490099 and manufactured by MONOBIND, INC. The registration is held by USA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including LDN LABOR DIAGNOSTIKA NORD GMBH & CO., DRG INSTRUMENTS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80048490099
25351144295201595
02330159000108
Company Information
Dates and Status
May 11, 2015
VIGENTE
09/18/2025 19:00:01
DEHIDROEPIANDROSTERONA (DHEA)
DHEA Test System โ ELISA
MONOBIND, INC
80048490102
Dec 23, 2024
DEHIDROEPIANDROSTERONA (DHEA)
EIA-3415 DHEA ELISA
DRG INSTRUMENTS GMBH
81905510079
May 08, 2023
DEHIDROEPIANDROSTERONA (DHEA)
DHEA ELISA
DRG INTERNATIONAL, INC.
10230730177
Jan 16, 2023
DEHIDROEPIANDROSTERONA (DHEA)
Dehidroepiandrosterona (DHEA) ELISA
EUROIMMUN AG
10338930241
Dec 10, 2020
DEHIDROEPIANDROSTERONA (DHEA)
DHEA Saliva ELISA
IBL INTERNATIONAL GMBH
80500080014
Dec 10, 2020

